Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Mastellos, Dimitrios C; Blom, Anna M; Connolly, E Sander; Daha, Mohamed R; Geisbrecht, Brian V; Ghebrehiwet, Berhane; Gros, Piet; Hajishengallis, George; Holers, V Michael; Huber-Lang, Markus; Kinoshita, Taroh; Mollnes, Tom E; Montgomery, Robert A; Morgan, B Paul; Nilsson, Bo; Pio, Ruben; Ricklin, Daniel; Risitano, Antonio M; Taylor, Ronald P; Mantovani, Alberto; Ioannidis, John P A; Lambris, John D.

Nat Immunol ; 20(11): 1556, 2019 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-31605100

2.

IgG Fc domains that bind C1q but not effector FcÎ³ receptors delineate the importance of complement-mediated effector functions.

Lee, Chang-Han; Romain, Gabrielle; Yan, Wupeng; Watanabe, Makiko; Charab, Wissam; Todorova, Biliana; Lee, Jiwon; Triplett, Kendra; Donkor, Moses; Lungu, Oana I; Lux, Anja; Marshall, Nicholas; Lindorfer, Margaret A; Goff, Odile Richard-Le; Balbino, Bianca; Kang, Tae Hyun; Tanno, Hidetaka; Delidakis, George; Alford, Corrine; Taylor, Ronald P; Nimmerjahn, Falk; Varadarajan, Navin; Bruhns, Pierre; Zhang, Yan Jessie; Georgiou, George.

Nat Immunol ; 18(8): 889-898, 2017 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-28604720

3.

'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Mastellos, Dimitrios C; Blom, Anna M; Connolly, E Sander; Daha, Mohamed R; Geisbrecht, Brian V; Ghebrehiwet, Berhane; Gros, Piet; Hajishengallis, George; Holers, V Michael; Huber-Lang, Markus; Kinoshita, Taroh; Mollnes, Tom E; Montgomery, Robert A; Morgan, B Paul; Nilsson, Bo; Pio, Ruben; Ricklin, Daniel; Risitano, Antonio M; Taylor, Ronald P; Mantovani, Alberto; Ioannidis, John P A; Lambris, John D.

Nat Immunol ; 20(11): 1409-1413, 2019 11.

Artigo em Inglês | MEDLINE | ID: mdl-31562490

4.

Antibody drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms.

Taylor, Ronald P; Lindorfer, Margaret A.

Blood ; 2024 Apr 21.

Artigo em Inglês | MEDLINE | ID: mdl-38643493

5.

Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.

Ivy, Zalaya K; Belcher, John D; Khasabova, Iryna A; Chen, Chunsheng; Juliette, Joseph P; Abdulla, Fuad; Ruan, Conglin; Allen, Kaje; Nguyen, Julia; Rogness, Victoria M; Beckman, Joan D; Khasabov, Sergey G; Gupta, Kalpna; Taylor, Ronald P; Simone, Donald A; Vercellotti, Gregory M.

Blood ; 142(22): 1918-1927, 2023 11 30.

Artigo em Inglês | MEDLINE | ID: mdl-37774369

6.

Corrigendum: IgG Fc domains that bind C1q but not effector FcÎ³ receptors delineate the importance of complement-mediated effector functions.

Lee, Chang-Han; Romain, Gabrielle; Yan, Wupeng; Watanabe, Makiko; Charab, Wissam; Todorova, Biliana; Lee, Jiwon; Triplett, Kendra; Donkor, Moses; Lungu, Oana I; Lux, Anja; Marshall, Nicholas; Lindorfer, Margaret A; Goff, Odile Richard-Le; Balbino, Bianca; Kang, Tae Hyun; Tanno, Hidetaka; Delidakis, George; Alford, Corrine; Taylor, Ronald P; Nimmerjahn, Falk; Varadarajan, Navin; Bruhns, Pierre; Zhang, Yan Jessie; Georgiou, George.

Nat Immunol ; 18(10): 1173, 2017 09 19.

Artigo em Inglês | MEDLINE | ID: mdl-28926542

7.

Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.

Gulati, Sunita; Beurskens, Frank J; de Kreuk, Bart-Jan; Roza, Marcel; Zheng, Bo; DeOliveira, Rosane B; Shaughnessy, Jutamas; Nowak, Nancy A; Taylor, Ronald P; Botto, Marina; He, Xianbao; Ingalls, Robin R; Woodruff, Trent M; Song, Wen-Chao; Schuurman, Janine; Rice, Peter A; Ram, Sanjay.

PLoS Biol ; 17(6): e3000323, 2019 06.

Artigo em Inglês | MEDLINE | ID: mdl-31216278

8.

T cells reinforce NK cell-mediated ADCC.

Taylor, Ronald P.

Blood ; 143(18): 1786-1787, 2024 May 02.

Artigo em Inglês | MEDLINE | ID: mdl-38696196

9.

Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.

Zhang, Yuzhou; Kremsdorf, Robin A; Sperati, C John; Henriksen, Kammi J; Mori, Mari; Goodfellow, Renee X; Pitcher, Gabriella R; Benson, Cindy L; Borsa, Nicolo Ghiringhelli; Taylor, Ronald P; Nester, Carla M; Smith, Richard J H.

Kidney Int ; 98(5): 1265-1274, 2020 11.

Artigo em Inglês | MEDLINE | ID: mdl-32540405

10.

Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.

Taylor, Ronald P; Lindorfer, Margaret A.

Semin Immunol ; 28(3): 309-16, 2016 06.

Artigo em Inglês | MEDLINE | ID: mdl-27009480

11.

Complement C1r serine protease contributes to kidney fibrosis.

Xavier, Sandhya; Sahu, Ranjit K; Bontha, Sai Vineela; Mass, Valeria; Taylor, Ronald P; Megyesi, Judit; Thielens, Nicole M; Portilla, Didier.

Am J Physiol Renal Physiol ; 317(5): F1293-F1304, 2019 11 01.

Artigo em Inglês | MEDLINE | ID: mdl-31509012

12.

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.

Oostindie, Simone C; van der Horst, Hilma J; Lindorfer, Margaret A; Cook, Erika M; Tupitza, Jillian C; Zent, Clive S; Burack, Richard; VanDerMeid, Karl R; Strumane, Kristin; Chamuleau, Martine E D; Mutis, Tuna; de Jong, Rob N; Schuurman, Janine; Breij, Esther C W; Beurskens, Frank J; Parren, Paul W H I; Taylor, Ronald P.

Haematologica ; 104(9): 1841-1852, 2019 09.

Artigo em Inglês | MEDLINE | ID: mdl-30792198

13.

Critical role of C5a in sickle cell disease.

Vercellotti, Gregory M; Dalmasso, Agustin P; Schaid, Terry R; Nguyen, Julia; Chen, Chunsheng; Ericson, Marna E; Abdulla, Fuad; Killeen, Trevor; Lindorfer, Margaret A; Taylor, Ronald P; Belcher, John D.

Am J Hematol ; 94(3): 327-337, 2019 03.

Artigo em Inglês | MEDLINE | ID: mdl-30569594

14.

Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.

Cook, Erika M; Lindorfer, Margaret A; van der Horst, Hilma; Oostindie, Simone; Beurskens, Frank J; Schuurman, Janine; Zent, Clive S; Burack, Richard; Parren, Paul W H I; Taylor, Ronald P.

J Immunol ; 197(5): 1762-75, 2016 09 01.

Artigo em Inglês | MEDLINE | ID: mdl-27474078

15.

Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.

Xavier, Sandhya; Sahu, Ranjit K; Landes, Susan G; Yu, Jing; Taylor, Ronald P; Ayyadevara, Srinivas; Megyesi, Judit; Stallcup, William B; Duffield, Jeremy S; Reis, Edimara S; Lambris, John D; Portilla, Didier.

Am J Physiol Renal Physiol ; 312(3): F516-F532, 2017 03 01.

Artigo em Inglês | MEDLINE | ID: mdl-28052876

16.

Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.

Taylor, Ronald P; Lindorfer, Margaret A; Cook, Erika M; Beurskens, Frank J; Schuurman, Janine; Parren, Paul W H I; Zent, Clive S; VanDerMeid, Karl R; Burack, Richard; Mizuno, Masashi; Morgan, B Paul.

Clin Immunol ; 181: 24-28, 2017 08.

Artigo em Inglês | MEDLINE | ID: mdl-28578024

17.

FcÎ³-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments.

Taylor, Ronald P; Lindorfer, Margaret A.

Blood ; 125(5): 762-6, 2015 Jan 29.

Artigo em Inglês | MEDLINE | ID: mdl-25498911

18.

Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia.

Lindorfer, Margaret A; Cook, Erika M; Reis, Edimara S; Ricklin, Daniel; Risitano, Antonio M; Lambris, John D; Taylor, Ronald P.

Clin Immunol ; 171: 32-35, 2016 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-27546448

19.

Null donors favor prepared immunologists.

Taylor, Ronald P.

Blood ; 133(13): 1389-1390, 2019 03 28.

Artigo em Inglês | MEDLINE | ID: mdl-30923104

20.

Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.

Baig, Nisar A; Taylor, Ronald P; Lindorfer, Margaret A; Church, Amy K; LaPlant, Betsy R; Pettinger, Adam M; Shanafelt, Tait D; Nowakowski, Grzegorz S; Zent, Clive S.

J Immunol ; 192(4): 1620-9, 2014 Feb 15.

Artigo em Inglês | MEDLINE | ID: mdl-24431228

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

IgG Fc domains that bind C1q but not effector FcÎ³ receptors delineate the importance of complement-mediated effector functions.

'Stealth' corporate innovation: an emerging threat for therapeutic drug development.

Antibody drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms.

Cold exposure induces vaso-occlusion and pain in sickle mice that depend on complement activation.

Corrigendum: IgG Fc domains that bind C1q but not effector FcÎ³ receptors delineate the importance of complement-mediated effector functions.

Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.

T cells reinforce NK cell-mediated ADCC.

Mutation of complement factor B causing massive fluid-phase dysregulation of the alternative complement pathway can result in atypical hemolytic uremic syndrome.

Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies.

Complement C1r serine protease contributes to kidney fibrosis.

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering.

Critical role of C5a in sickle cell disease.

Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.

Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis.

Hexamerization-enhanced CD20 antibody mediates complement-dependent cytotoxicity in serum genetically deficient in C9.

FcÎ³-receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments.

Compstatin Cp40 blocks hematin-mediated deposition of C3b fragments on erythrocytes: Implications for treatment of malarial anemia.

Null donors favor prepared immunologists.

Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia.